Two SymphonyAI Group health tech companies have merged to form an expanded AI patient outreach and personalized care company.
Related Posts
Reach7 CEO Talks Reimagining Diabetes Care with Membership-Based Studio Clinics
Chun Yong, CEO at Reach7 Diabetes Studios Today’s landscape of diabetes care is fraught with challenges: it’s a condition that’s often misunderstood by both patients […]
Will the UK (finally) increase drug prices? – Healthcare Economist
President Trump’s May 12 Executive Order around Most-Favored-Nation drug pricing argues that countries outside the US need to raise their prices on pharmaceuticals saying that […]
Idiopathic Pulmonary Fibrosis (IPF) | Symptoms & Treatment
Idiopathic pulmonary fibrosis, a relatively rare name a few years back, has seen a significant jump in cases in the past few years, mainly the […]